Morgan Stanley’s Maverix Metals Inc. Common Shares MMX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
Sell
-246,491
Closed -$1.15M 7987
2022
Q4
$1.15M Buy
246,491
+19,146
+8% +$73.9K ﹤0.01% 4791
2022
Q3
$762K Buy
227,345
+29,861
+15% +$113K ﹤0.01% 5044
2022
Q2
$860K Buy
197,484
+101,144
+105% +$460K ﹤0.01% 5107
2022
Q1
$462K Buy
96,340
+27,133
+39% +$125K ﹤0.01% 5450
2021
Q4
$302K Buy
69,207
+17,265
+33% +$81.2K ﹤0.01% 5838
2021
Q3
$232K Sell
51,942
-3,002
-5% -$14.3K ﹤0.01% 5919
2021
Q2
$296K Sell
54,944
-2,959
-5% -$16.9K ﹤0.01% 5820
2021
Q1
$305K Buy
57,903
+20,165
+53% +$107K ﹤0.01% 5415
2020
Q4
$207K Buy
37,738
+7,338
+24% +$38.4K ﹤0.01% 5572
2020
Q3
$156K Sell
30,400
-11,300
-27% -$52.9K ﹤0.01% 5227
2020
Q2
$185K Buy
41,700
+40,518
+3,428% +$174K ﹤0.01% 5112
2020
Q1
$4K Buy
1,182
+214
+22% +$957 ﹤0.01% 6291
2019
Q4
$5K Sell
968
-2,332
-71% -$10.1K ﹤0.01% 6404
2019
Q3
$13K Buy
3,300
+2,900
+725% +$13.5K ﹤0.01% 6140
2019
Q2
$2K Buy
+400
New +$1.76K ﹤0.01% 6490

Other funds holding MMX

Morgan Stanley's MMX Position: Q1 2023 in Review

Morgan Stanley sold out of Maverix Metals Inc. Common Shares (MMX) in Q1 2023, closing a stake of 246,491 shares — an estimated $1.15M sold.

Morgan Stanley first reported a position in MMX in Q2 2019 and held it in 15 quarters. The position peaked at $1.15M in Q4 2022. 2 funds tracked by Wall St. Rank hold MMX as of Q1 2023.

  • Morgan Stanley reported no remaining Maverix Metals Inc. Common Shares position as of Q1 2023 after selling out during the quarter.
  • Morgan Stanley sold 246,491 Maverix Metals Inc. Common Shares shares in Q1 2023, an estimated $1.15M.
  • Morgan Stanley first reported a position in Maverix Metals Inc. Common Shares in Q2 2019 and held it in 15 quarters.
  • Morgan Stanley's Maverix Metals Inc. Common Shares position peaked at $1.15M in Q4 2022.
  • 2 funds tracked by Wall St. Rank held Maverix Metals Inc. Common Shares as of Q1 2023.

Based on Morgan Stanley's 13F filing for Q1 2023, filed 15 May 2023.